Media Centre
Latest press releases
-
AstraZeneca expands company’s $100m+ commitment to advance youth health equity in more than 60 countries
-
Trixeo approved in the EU for the maintenance treatment of asthma
-
Klygefa (gefurulimab) recommended for approval in the EU by CHMP for the treatment of adults with generalised myasthenia gravis (gMG)
-
Enhertu recommended for approval in the EU by CHMP as adjuvant treatment for patients with residual disease after neoadjuvant treatment for HER2-positive early breast cancer
-
Efzimfotase alfa granted Priority Review in the US as treatment for patients with hypophosphatasia aged 2 years and older
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
